X0202 3 2004-04-28 0 0001173657 BARRIER THERAPEUTICS INC BTRX 0001106607 JP MORGAN PARTNERS BHCA LP C/O J.P. MORGAN PARTNERS 1221 AVENUE OF THE AMERICAS 40TH FLOOR NEW YORK NY 10020 0 0 1 0 0001243235 JPMP MASTER FUND MANAGER L P C/O JP MORGAN PARTNERS LLC 1221 AVENUE OF THE AMERICAS 40TH FLOOR NEW YORK NY 10020 0 0 1 0 0001243236 JPMP CAPITAL CORP C/O J.P. MORGAN PARTNERS, LLC 1221 AVENUE OF THE AMERICAS 40TH FLOOR NEW YORK NY 10020 0 0 1 0 0000019617 J P MORGAN CHASE & CO 270 PARK AVE 39TH FL NEW YORK NY 10017 0 0 1 0 0001162622 JP MORGAN PARTNERS GLOBAL INVESTORS LP C/O J.P. MORGAN PARTNERS, LLC 1221 AVENUE OF THE AMERICAS 40TH FLOOR NEW YORK NY 10020 0 0 1 0 0001169890 J P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN LP C/O J P MORGAN PARTNERS 1221 AVENUE OF THE AMERICAS 40TH FL NEW YORK NY 10020 0 0 1 0 0001167095 J P MORGAN PARTNERS GLOBAL INVESTORS A LP 1221 AVENUE OF THE AMERICAS 40TH FLOOR NEW YORK NY 10020 0 0 1 0 0001169889 J P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN II LP C/O J P MORGAN PARTNERS 1221 AVENUE OF THE AMERICAS 40TH FL NEW YORK NY 10020 0 0 1 0 0001281161 JPMP GLOBAL INVESTORS L P 1221 AVENUE OF THE AMERICAS 40TH FLOOR NEW YORK NY 10021 0 0 1 0 Series B Convertible Preferred Stock Common Stock 4201280.000 D Series B Convertible Preferred Stock Common Stock 665744.000 I See Footnote Series B Convertible Preferred Stock Common Stock 337900.0000 I See Footnote Series B Convertible Preferred Stock Common Stock 90754.0000 I See Footnote Series B Convertible Preferred Stock Common Stock 37657.0000 I See Footnote Series C Convertible Preferred Stock Common Stock 740321.0000 D Series C Convertible Preferred Stock Common Stock 130207.0000 I See Footnote Series C Convertible Preferred Stock Common Stock 65370.0000 I See Footnote Series C Convertible Preferred Stock Common Stock 20007.0000 I See Footnote Series C Convertible Preferred Stock Common Stock 7310.0000 I See Footnote All of the outstanding shares of the Issuer's Series B Convertible Preferred Stock and Series C Convertible Preferred Stock will convert automatically on a 2 for 1 basis into Common Stock of the Company prior to the Issuer's initial public offering. These shares are convertible on a 2 for 1 basis. The amount shown represents the beneficial ownership of the Issuer's equity securities by J.P. Morgan Partners Global Investors, L.P. The amount shown represents the beneficial ownership of the Issuer's equity securities by J.P. Morgan Partners Global Investors (Cayman), L.P. The amount shown represents the beneficial ownership of the Issuer's equity securities by J.P. Morgan Partners Global Investors A, L.P. The amount shown represents the beneficial ownership of the Issuer's equity securities by J.P. Morgan Partners Global Investors (Cayman) II, L.P. Damion Wicker M.D. 2004-04-27